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Increasing evidence is emerging highlighting the role of parathyroid hormone-related protein (PTHrP) during metastasis by regulating
cell adhesion. The current study demonstrated that modulation of PTHrP expression by PTHrP overexpression and small interfering
RNA-induced silencing resulted in changes in cell adhesion and integrin expression. RNA interference of endogenous PTHrP caused a
significant reduction in cell adhesion of a breast cancer cell line to collagen type I, fibronectin and laminin (Po0.05) and of a colon
cancer cell to collagen type I and fibronectin (Po0.05). Overexpression of PTHrP induced a significant increase in cell adhesion of
colon (Po0.0001) and breast (Po0.05) cancer cells to the same extracellular matrix proteins. These PTHrP-mediated effects were
attributed to changes in integrin expression as the differences in adhesion profile correlated with the integrin expression profile. In an
attempt to elucidate the mechanism whereby PTHrP regulates integrin expression, promoter activity of the integrin a5 subunit was
analysed and significant increases in transcriptional activity were observed in PTHrP overexpressing cells (Po0.0001), which was
dependent on nuclear localisation. These results indicate that modulation of cell adhesion is a normal physiological action of PTHrP,
mediated by increasing integrin gene transcription.
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Parathyroid hormone-related protein (PTHrP) was initially
discovered as the cause of humoral hypercalcaemia of malignancy.
Subsequent research has identified several normal physiological
actions including growth and development, calcium homeostasis
and smooth muscle relaxation (Wysolmerski and Broadus, 1994).
Parathyroid hormone-related protein acts locally in an autocrine,
paracrine or intracrine manner (Broadus et al, 1985; Burtis et al,
1987; Suva et al, 1987) with intracrine activity being the result of
translocation to the nucleus, mediated by a bipartite nuclear
localisation sequence (NLS) within the mid-region of the PTHrP
peptide (Nguyen and Karaplis, 1998). Nuclear-localised PTHrP has
been shown to be both mitogenic and antiapoptotic (Aarts et al,
2001; Tovar Sepulveda et al, 2002).
Increased expression of PTHrP has been described in a variety
of tumour types, including gastrointestinal (GI) (Sidler et al, 1996;
Alipov et al, 1997), but is most commonly associated with breast
cancer. Furthermore, as high PTHrP expression has been identified
in subsequent metastases (in particular bone), it has also been
suggested that PTHrP plays a key role in tumour progression
(Southby et al, 1990).
Ye et al (2001) examined the role of PTHrP in tumour growth
and progression in a colon cancer cell line and demonstrated that
overexpression of PTHrP in HT29 cells caused an increase in cell
adhesion to the extracellular matrix (ECM) protein collagen type I.
Adhesion to fibronectin and laminin was unaffected which led
the authors to suggest that this selective increase in adhesion
facilitated tumour cell metastasis to specific organs.
Subsequent investigations conducted by Shen and Falzon
utilised cell lines derived from three different tissues (prostate,
colonic and breast; PC3, LoVo and MCF-7, respectively), which
showed that overexpression of PTHrP causes a significant increase
in prostate and colon cancer cell adhesion to collagen type I,
fibronectin and laminin and an increase in breast cancer cell
adhesion to laminin only (Shen and Falzon, 2003a,b, 2005; Shen
et al, 2004). Shen and Falzon explored the mechanism by which
PTHrP regulates adhesion by examining expression of the
transmembrane cell adhesion receptors, integrins, which mediate
cell–matrix and cell–cell adhesion (Hynes, 2002). Shen and
Falzon’s examination of integrin cell surface expression revealed
an increase in expression of a number of integrin subunits
following PTHrP overexpression and that the effect of PTHrP on
integrin expression was mediated via an intracrine pathway, yet
the mechanism involved was not determined.
Furthermore, it is not known whether integrin expression and
adhesion are affected by endogenous PTHrP. Also, despite the
suggestion that an intracrine pathway is involved, the mechanism
whereby PTHrP increases integrin expression is as yet unknown.
The aims of the present study were to determine the effects of
endogenous PTHrP expression on adhesion and integrin
expression.
MATERIALS AND METHODS
Materials
The ECM proteins human fibronectin and mouse laminin-1
(derived from the EHS tumour) were purchased from BD
Biosciences (Oxford, UK), whereas collagen type I (from rat tail)
was obtained from Sigma Aldrich (Poole, UK). Anti-a2,- a5,- a6,- b1
and -b4 antibodies were purchased from BD Biosciences (Oxford,
UK).
Received 30 October 2006; revised 20 February 2007; accepted 7 March
2007; published online 3 April 2007
*Correspondence: Professor SA Watson, Division of Pre-Clinical
Oncology, D Floor, West Block, Queen’s Medical Centre, University
Hospital, Nottingham NG7 2UH, UK;
E-mail: sue.watson@nottingham.ac.uk
British Journal of Cancer (2007) 96, 1394–1403
& 2007 Cancer Research UK All rights reserved 0007– 0920/07 $30.00
www.bjcancer.com
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sCell culture
MDAMB231 (human breast adenocarcinoma) and HT29 (human
colonic adenocarcinoma) cell lines were purchased from the
European Collection of Cell Cultures (Porton Down, UK) (nos.
92020424 and 91072201, respectively). MGLVA1 ascites is a human
gastric cell line derived from a human gastric adenocarcinoma
within the Division of Pre-Clinical Oncology (University of
Nottingham, Nottingham, UK). All of the cell lines were cultured
in RPMI 1640 medium (Sigma Aldrich) supplemented with 10%
heat-inactivated fetal bovine serum and 2mML -glutamine (Sigma
Aldrich) and grown at 371C in a humidified 5% CO2 atmosphere.
Semiconfluent cell monolayers were harvested using 0.025% EDTA
in phosphate-buffered saline (PBS), pH 7.2 (Sigma Aldrich).
Construction of cell lines stably transfected with PTHrP
PTHrP overexpressing cell lines were created using expression
vectors containing cDNA coding for amino acids  36 to þ139 of
human PTHrP, which had been cloned in the sense orientation
into the expression vector pcDNA3.1(þ) (Invitrogen, Paisley, UK)
and were a generous gift from Professor Miriam Falzon (University
of Texas, TX, USA). A second construct also contained cDNA
coding for amino acids  36 to þ139 but was mutated in the NLS:
residues 88–91 and 102–106 had been deleted using a Transfor-
mer Site-Directed Mutagenesis Kit. These two constructs along
with the empty vector control were transfected into MDAMB231
and HT29 cells using Lipofectamine 2000 (Invitrogen). Briefly, for
each well undergoing transfection 2ml of Lipofectamine 2000 was
diluted in 50ml Opti-MEM I (Invitrogen) and incubated for 5min
at room temperature; 500ng plasmid DNA was similarly diluted
in 50ml Opti-MEM I. The DNA and Lipofectamine 2000 were
combined and incubated for a further 20min at room temperature
to promote formation of transfection complexes. These complexes
were then added to previously seeded cells and incubated at 371C,
5% CO2. Two days following transfection, 500mgml
 1 G418 (Sigma
Aldrich) was used to select transfected cells with individual clones
grown in 96-well plates before expansion into tissue culture flasks.
Clones were maintained in growth medium supplemented with
G418 and tested for PTHrP expression by RT–PCR.
RNA interference
Small interfering RNAs (siRNA) were synthesised using the
Silencer siRNA Construction kit (Ambion, Austin, TX, USA). The
target sequences are given in Table 1.
All siRNAs were transiently transfected. PTHrP siRNAs were
reverse-transfected as follows: 5 10
4cells per well were seeded
into 24-well plates, cultured overnight and transfected in Opti-
MEM I serum-free medium using siPORT Amine (Ambion),
according to the manufacturer’s instructions. For each well
undergoing transfection, 2ml of siPORT Amine was combined
with 47ml of Opti-MEM I and incubated at room temperature for
30min before the addition of 1ml siRNA. Unless otherwise stated, a
final siRNA concentration of 800pM was used. To allow formation
of the siRNA/siPORT complexes, samples were incubated at room
temperature for 15–20min. The medium was removed from the
previously seeded cells and replaced with 200ml of fresh growth
medium and the transfection reagents added dropwise onto the
cells.
Integrin siRNAs were forward-transfected as follows: for each
well undergoing transfection, 2ml of siPORT Neofx was combined
with 23ml of Opti-MEM I-reduced serum media and incubated at
room temperature for 10min. Small interfering RNAs were diluted
to their final concentration of 5nM (unless otherwise stated) using
Opti-MEM I and then combined with the previously diluted
siPORT Neofx. The mixture was again incubated for 10min at
room temperature to allow the formation of transfection
complexes, which were then dispensed into the empty well of a
24-well plate. A 450ml portion of cell suspension
(1 10
5cellsml
 1) was then added to each well and incubated at
371C, 5% CO2 to promote transfection.
Real-time PCR
RNA was extracted using RNA-Bee (Biogenesis, Poole, UK) and
reverse-transcribed from random hexamer primers (Amersham
Biosciences, Little Chalfont, UK) using Superscript RT (Invitro-
gen). Real-time PCR was performed using the 7500 Real-time PCR
System (Applied Biosystems, Warrington, UK) in conjunction with
the fluorescent DNA binding dye, SYBR green. The sequences of
the RT–PCR primers are given in Table 2. In addition, OAS and
STAT gene expression was examined using ABI Taqman primer
sets labelled with the fluorescent reporter dye FAM, which negated
the need for SYBR green. An equivalent hypoxanthine guanine
phosphoribosyl transferase (HPRT) set was used as a control for
these primers. Relative gene expression was determined using the
2 DDCt model (Livak and Schmittgen, 2001) and HPRT used to
normalise gene expression levels.
Cell adhesion assay
Ninety-six-well tissue culture plates were precoated with 5mgml
 1
of either collagen type I, fibronectin or laminin in a total volume of
50ml and incubated for 1h at room temperature. Nonspecific
Table 1 siRNA target sequences
SiRNA Target sequence
PTHrP target 4 AAGGGGAAGTCCATCCAAGAT
PTHrP target 19 AAGACACCTGGGAAGAAAAAG
PTHrP target 28 AAGAAAAAACGGCGAACTCGC
PTHrP target 19 scrambled AAGCACAAAGAGATGGAGAAC
Integrin a5 AAGAATCTCAACAACTCGCAAAGCGAC
Integrin a6 AAACATGGACCTTGATCGAAATTCCTA
Scrambled integrin a5 AACCCTCGGACCTTAAGCAGAAACAAA
PTHrp¼parathyroid hormone-related protein.
Table 2 Oligonucleotide primer pairs used during RT–PCR
Target gene Primer sequence 50-30
HPRT F GACCAGTCAACAGGGGACAT
R CGACCTTGACCATCTTTGGA
PTHrP F GCTCGGTGGAGGGTCTCA
R TTGTCATGGAGGAGCTGATGTT
a2 F AACATCCCAGACATCCCAAT
R ATCATGTGATTCACCGTCAG
a5 (Oki et al, 2004) F GGCAGCTATGGCGTCCCACTGTGG
R CATCAGAGGTGGCTGGAGGCTT
a6 F TCAATTGCTGGAAACATGGA
R GGCGGAGGTCAATTCTGTTA
b1 (Oki et al, 2004) F GTGGTTGCTGGAATTGTTCTTATT
R TTTTCCCTCATACTTCGGATTGAC
b4 (Utermark et al, 2003) F ATAGAGTCCCAGGATGGAGGA
R GTGGTGGAGATGCTGCTGTA
HPRT¼hypoxanthine guanine phosphoribosyl transferase; PTHrP¼parathyroid hor-
mone-related protein; RT–PCR¼reverse transcriptase–polymerase chain reaction.
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 1 bovine serum albumin
(BSA, Sigma Aldrich) in PBS for 1h at room temperature. A total
of 5 10
4 cells were added to each well and incubated at 371C, 5%
CO2 for 1h before non-adherent cells were removed following
gentle washing. The number of attached viable cells was quantified
using MTT uptake as follows: cells were incubated with 1mgml
 1
MTT for 4h then excess MTT removed and the remaining
formazan crystals solubilised using dimethyl sulfoxide (Sigma
Aldrich). The amount of solubilised formazan product was then
photometrically quantified using an MRX microplate reader at a
wavelength of 550nm and the number of viable cells used as a
measure of the number of adherent cells. Results are expressed as
percentage of control:
adhesionð%Þ¼
meanabsorbanceof testcells
meanabsorbanceof controlcells

 100
Analysis of integrin cell surface levels by flow cytometry
A cell pellet of 2 10
5 cells was washed twice with 1ml PBA (PBS
containing 5% BSA and 0.2% sodium azide) then incubated with
the relevant primary antibody for 30min at 41C. Subsequent
washes were followed by a further 30-min incubation with a FITC-
conjugated rabbit anti-mouse secondary antibody (DAKO) again
at 41C. Stained cells were then washed and fixed in 1% formalin
(formaldehyde in PBS). The fluorescent intensity was measured on
a Beckman Coulter FACS analysis machine and analysed using
WinMDI analysis software (facs.scripps.edu/software.html).
PTHrP protein detection by Western blot
Five days following siRNA transfection, cell lysates (prepared using
buffer containing 250mM NaCl, 20mM Tris-HCl, 0.5% Triton
X-100, 3mM EDTA, 3mM EGTA, 1mM PMSF, 1mM DTT) were
centrifuged at 13000g for 15min at 41C. The supernatant, which
represents the cytoplasmic fraction, was removed and the pellet,
which represents the nuclear fraction, was washed twice in lysis
buffer and resuspended in RIPA buffer (137mM NaCl, 20mM Tris-
HCl, 10% glycerol, 1% Igepal, 0.1% SDS, 0.5% sodium deoxycho-
late, 2mM EDTA, 2mM Na3VO4,1m M DTT, 1mM PMSF, 5mgml
 1
leupeptin, 20mgml
 1 aprotinin) used to extract the nuclear
fraction. Proteins were separated on 12% NuPAGE gels (Invitrogen)
before transfer to nitrocellulose membranes, which were blocked
with 5% Marvel in TBS before being probed with a monoclonal
anti-PTHrP (1–34) antibody at 1mgml
 1 (Aphton Corporation,
Woodland, CA, USA) overnight at 41C. To allow chemiluminescent
visualisation using ECL reagent (Amersham), a biotin-conjugated
rabbit anti-mouse secondary antibody (1:1000, DAKO) was applied
to the membrane. Luminescence was visualised using GeneSnap
software in conjunction with a Chemi Genius
2 BioImaging System
(Syngene) with the intensity of the bands present on the
membranes being proportional to the amount of bound secondary
antibody and hence amount of target protein present in the
sample. Band intensities were also calculated using the Chemi
Genius
2 BioImaging System.
Integrin reporter construct
The a5 promoter region (initially characterised by Birkenmeier
et al, (1991)) contains consensus binding sites for a number of
different elements, including Ets, Sp1, AP1 and AP2. The promoter
region (from  926 to þ23) was amplified using the following
opposing primers, which contained restriction sites for KpnI and
BglII, respectively (underlined), and then cloned into a pGL3-Basic
vector (Promega, Southampton, UK) using T4 ligase:
CGGGTACCGTTTACACCGATTAGGAGCTGAAGGT, and GAGA
GATCTTCCTAAACCTCCCAGAGGCG (Klein et al, 1996). Reporter
constructs were transfected into cells using Lipofectamine 2000 as
described above.
Luciferase assay
Luciferase activity was measured using the Stop&Glo system
(Promega, Southampton, UK). At 24h after reporter construct
transfection, cells were lysed at room temperature using 100mlo f
lysis buffer. The lysates were then mixed with an equal volume of
Steady-Glo Assay Reagent in a solid black 96-well plate. Following
a 5-min incubation at room temperature, luminescence was
analysed using a MicroLumi XS Microplate Luminometer.
Data analysis
Results from MTT adhesion assays are presented as mean7s.e.m.
of 15 wells (three independent assays performed in quintuplicate)
and analysed using one-way ANOVA. RT–PCR data are presented
as the mean795% confidence intervals of nine wells (three
independent experiments performed in triplicate) and analysed
using a Student’s t-test. Flow cytometry results shown were
analysed using one-way ANOVA and the results shown are from
three independent experiments, 7s.d. Luciferase assay data were
analysed using a Student’s t-test and are presented as 7s.e.m. of
nine wells (three independent assays performed in triplicate).
Values of Po0.05 are considered significant.
RESULTS
Evaluation of PTHrP expression in stably transfected cell
lines
To investigate the role of PTHrP in cell adhesion and integrin
expression cells were transfected to overexpress endogenous
PTHrP (upregulation) using constructs encoding PTHrP and
PTHrP in which the NLS had been mutated through the deletion
of the bipartite NLS (residues 88–91 and 102–106) by site-directed
mutagenesis. These constructs were a generous gift from Professor
Miriam Falzon (University of Texas). Previous studies by Falzon
et al have shown that PC-3 cells transfected with both the wild-type
and NLS-mutated PTHrP constructs secrete significantly greater
amounts of PTHrP than untransfected or empty vector transfected
cells (Tovar Sepulveda and Falzon, 2002). Using immunofluores-
cence, the same study detected nuclear and cytoplasmic staining in
PC-3 cells containing the wild-type PTHrP construct with B60%
of cells demonstrating nuclear staining; however, cells containing
the NLS-mutant PTHrP exhibited strong cytoplasmic staining with
nuclear staining visible in p10% of cells.
For the present study, stable clones were established and PTHrP
expression examined by RT–PCR. Parathyroid hormone-related
protein gene expression in both MDAMB231 and HT29 cells
transfected with the vector control was similar to that found in
the corresponding wild-type cells. Cells stably transfected to
overexpress wild-type and NLS-mutated PTHrP exhibited an
increase in PTHrP expression between 1000- and 10000-fold
compared with vector-control cells (Figure 1, Po0.0001) and two
individual clones for each cell line and construct were selected for
further analysis.
Knockdown of endogenous PTHrP using interfering RNA
Initial optimisation studies of an siRNA designed to knockdown
endogenous PTHrP was conducted in the gastric cancer cell line
MGLVA1 ascites, which has been shown to express high levels of
PTHrP (Figure 2A). To silence PTHrP expression, three siRNAs
targeted against different regions of the PTHrP gene were tested at
increasing concentrations for their ability to significantly reduce
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induce a decrease in gene expression of 480% (Po0.0001) at the
maximal concentration used; however, the most effective of the
three siRNAs, Tgt19, was able to decrease gene expression by
X90% (Po0.0001) even at the lowest concentration used and was
therefore used during subsequent studies at a final concentration
of 800pM.
PTHrP protein expression was also examined following siRNA
transfection using Western blotting (Figure 2C). Densitometry
analysis revealed a maximal decrease in protein expression of 41.0
and 43.8% in MDAMB231 and HT29 cells, respectively, 5 days after
transfection with Tgt19 when compared with cells transfected with
a scrambled version of the Tgt19 siRNA (Figure 2D).
Several studies have demonstrated the induction of the interferon
response upon the introduction of dsRNA (Bridge et al, 2003;
Sledz et al, 2003) and consequently OAS and STAT gene expre-
ssion (key components of the interferon response) were examined
in cells transfected with the Tgt19 siRNA. No change in expression
of either gene was detected following siRNA transfection
(Figure 2E).
Manipulation of PTHrP results in significant changes in
cell adhesion
Adhesion of clones overexpressing PTHrP was investigated in
MDAMB231 and HT29 cells. Overexpression of wild-type PTHrP
in MDAMB231 cells caused an increase in ECM adhesion: both
clones demonstrated a significant increase in adhesion to collagen
type I (Po0.05), fibronectin (Po0.001) and laminin (Po0.0001)
(Figure 3A) compared with vector control cells whereas PTHrP-
overexpressing HT29 cells demonstrated a significant increase in
adhesion to collagen type I and fibronectin only (Figure 3B,
Po0.0001). Despite demonstrating a significant increase in
PTHrP expression, adhesion of both HT29 and MDAMB231 cells
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Figure 2 PTHrP knockdown. (A) Endogenous PTHrP expression in MGLVA1 ascites, MDAMB231 and HT29 cell lines, expressed relative to
MDAMB231 cells. (B) The effect of increasing concentrations of three siRNA homologous to different regions of the PTHrP gene on gene expression in
MGLVA1 ascites, 24h after transfection and relative to GAPDH siRNA (Po0.0001). (C) PTHrP and b-actin protein expression in MDAMB231 and HT29
cells 5 days after transfection with 800pM of either scrambled control or Tgt19 siRNA. (D) Percentage decrease in PTHrP protein expression in
MDAMB231 and HT29 cells transfected with Tgt19 siRNA, as determined by densitometry analysis and expressed relative to scrambled control siRNA. (E)
The effect of Tgt19 siRNA transfection on OAS and STAT gene expression in MDAMB231 and HT29 cells, expressed relative to scrambled control siRNA.
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vector control transfected cells.
PTHrP was silenced in MDAMB231 (Figure 4A) and HT29
(Figure 4B) cells by siRNA and cell adhesion examined 5 days
post-transfection when the protein downregulation was maximal.
A small but significant reduction of B15% in MDAMB231 cell
adhesion to collagen type I (Po0.05), fibronectin (Po0.05) and
laminin (Po0.05) was observed. HT29 cell adhesion to laminin
was unaffected by PTHrP silencing; however, there was a 25%
decrease in adhesion to collagen type I (Po0.0001) and a 20%
decrease in adhesion to fibronectin (Po0.0001).
Effect of PTHrP modulation on integrin subunit
expression
To investigate the mechanism underlying the changes in adhesion
of cells over- or underexpressing PTHrP, expression of several
integrin subunits was examined. Expression of wild-type PTHrP
in MDAMB231 cells resulted in a significant increase in gene
expression of the integrin subunits a5, a6, b1 and b4 (Figure 5A,
Po0.0001). Expression was not significantly affected in cells
expressing NLS-mutated PTHrP when compared to vector control,
and no change in expression of a2 was detected in any of the clones
examined.
In HT29 cells, gene expression of the subunits a5 and b1 was
significantly higher in cells expressing wild-type PTHrP compared
with vector control whereas expression of subunits a2, a6 and b4
was unaltered (Figure 5B, Po0.0001). Again, mutation of the NLS
reversed the effects of PTHrP overexpression.
Integrin cell surface expression was also examined in each of
the MDAMB231 and HT29 clones. In MDAMB231 cells expressing
wild-type PTHrP, the change in cell surface expression corre-
sponded with the previously observed changes in gene expression
with no change in expression of a2 and a significant increase
in expression of a5, a6, b1 and b4 (Figure 5C, Po0.0001). The
integrin cell surface expression in HT29 clones also correlated with
the gene expression profile with an increase in wild-type PTHrP
resulting in a significant increase in expression of a5 and b1
(Figure 5D, Po0.0001), but no change in expression of a2, a6 or b4
in either the wild-type or NLS-mutant clones.
Five days following transient transfection with the Tgt19 siRNA,
there was a significant decrease in gene expression of a5 and b1 in
both MDAMB231 and HT29 cells compared with scrambled
control (Figure 6A, Po0.0001). There was also a significant
decrease in expression of and a6 and b4 expression in MDAMB231
cells (Po0.0001).
Changes in integrin cell surface expression corresponded with the
previously observed decreases in gene expression with a significant
decrease in cell surface a5 and b1 expression in both MDAMB231
and HT29 cells transfected with Tgt19 and a decrease in expression
of a6 and b4 in only MDAMB231 cells (Figure 6B, Po0.0001).
PTHrP counteracts the effects of an integrin siRNA
To examine further the role of integrins in PTHrP’s ability to
increase adhesion, the integrin subunits a5 and a6 were knocked
down using siRNA. Recent work by Kim et al (2005) demonstrated
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Figure 3 Cell adhesion of PTHrP overexpressing (A) MDAMB231 and
(B) HT29 cells to the ECM proteins collagen type I, fibronectin and laminin,
compared with vector control cells (*Po0.05, **Po0.001 and
***Po0.0001).
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Figure 4 Adhesion of (A) MDAMB231 and (B) HT29 cells to collagen
type I, fibronectin and laminin five days after transient transfection with
either Tgt19 siRNA or scrambled control (*Po0.05, **Po0.0001).
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sthat increasing siRNA length also increases potency and showed
27nt to be the optimal siRNA length. When attempting to silence
integrin expression, 27mer siRNAs directed towards a5 and a6 were
constructed and compared with corresponding 21mer siRNAs. In
each case, the longer siRNA was indeed shown to be more potent
than the shorter version. For example, the 27mer a5 siRNA was
able to reduce gene expression by B60% at the lowest concentra-
tion used (50pM) whereas the corresponding 21mer was unable to
significantly reduce gene expression (data not shown). Indeed,
both the a5 and a6 27mer siRNAs were able to reduce significantly
a5 and a6 gene expression using concentrations as low as 50pM
when gene expression was examined 24h after transfection
(Figure 7A, Po0.0001). Similar to the gene expression results,
there was a significant decrease in protein expression with both
integrin siRNAs compared with scrambled control (Figure 7B,
*Po0.001, **Po0.0001). Neither integrin siRNA induced the
interferon response (data not shown).
It can be seen in Figure 7C that following transfection with the
a5 siRNA there was a significant reduction in cell adhesion to
fibronectin compared with the scrambled control but no decrease
in cell adhesion to either laminin or collagen type I (Po0.0001).
Similarly using the a6 siRNA, adhesion to laminin significantly
decreased with transfection of the target siRNA compared with
scrambled control (Po0.0001), whereas there was no decrease in
adhesion to collagen or fibronectin. These results indicate that the
downstream effects of silencing either integrin siRNA were specific
to the targeted ligand only.
When protein expression was examined, overexpression of wild-
type PTHrP in HT29 cells resulted in a reduction in the degree of
a5 knockdown in these cells compared with vector control and
NLS-deleted cells but had no effect on silencing of the a6 subunit.
In HT29 vector control cells, there was a B50% knockdown in
protein expression in a5 siRNA-transfected cells compared with
scrambled control-transfected cells whereas there was only a
B20% knockdown in wild-type expressing cells. Likewise, in
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sMDAMB231 cells expressing wild-type PTHrP, there was a
knockdown of a5 expression of only B30% compared with a
knockdown of B50% in vector control cells (Figure 7D). It can
also be seen in Figure 7D that the protein knockdown following a6
siRNA transfection was similar in all of the HT29 cell lines whereas
in the MDAMB231 cells there was a knockdown of B50% in vector
control cells and only a knockdown of B20% in wild-type
overexpressing cells (Po0.0001).
Figure 7E and F show that when the effect of a5 and a6 siRNA
transfection on cell adhesion was examined, whereas there was a
significant decrease in adhesion in each of the cell lines examined,
the nuclear translocation of PTHrP caused a smaller reduction in
adhesion of a5-transfected HT29 cells to fibronectin (B15%
decrease compared with a 30% decrease in adhesion in vector
control cells), but adhesion to laminin was similar in each of cell
lines examined. Both integrin siRNA caused a significant reduction
in MDAMB231 cell adhesion to fibronectin and laminin and again
the presence of PTHrP within the cell nucleus appears to diminish
the reduction of siRNA-induced adhesion. Both siRNA reduced
adhesion to fibronectin and laminin by B15% in wild-type
overexpressing cells, whereas adhesion to laminin was reduced by
up to 40% in vector control cells (Po0.0001).
PTHrP overexpression causes an increase in a5 gene
transcription
Analysis of integrin expression following manipulation of PTHrP
expression appeared to demonstrate that PTHrP affected integrin
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sexpression at the gene level, which was then translated to similar
changes at the protein level. To investigate the mechanism
involved, the promoter region of the a5 gene was cloned into a
reporter construct upstream of firefly luciferase. This subunit was
chosen as it had shown a link to PTHrP expression in both
MDAMB231 and HT29 cells.
The reporter construct was transiently transfected into the
PTHrP overexpressing clones and changes in luciferase activity
examined. Following transient transfection with the integrin
reporter construct, there was an average 10- and 25-fold increase
in promoter activity in MDAMB231 and HT29 cells overexpressing
wild-type PTHrP, respectively, compared with the vector control
cell line (Figure 8, Po0.0001). Cells expressing NLS-mutant PTHrP
did not demonstrate any increase in luminescence compared with
vector control cells.
DISCUSSION
The results described here show that regulation of cell–ECM
adhesion via transcriptional regulation of integrin expression is a
normal function of endogenous PTHrP, as well as supporting
previous studies showing that overexpression of PTHrP results in
upregulation of integrin expression and thereby affects cell
adhesion (Ye et al, 2001; Shen and Falzon, 2003a,b, 2005; Shen
et al, 2004).
Cell–ECM adhesion was examined following PTHrP gene
silencing and a significant reduction in adhesion to collagen type
I and fibronectin observed in both a breast and colon cell line. In
MDAMB231, a reduction in cell adhesion to laminin was also
demonstrated.
This paralleled the data obtained using PTHrP overexpressing
stable transfectants encoding for wild-type PTHrP, where over-
expression in MDAMB231 and HT29 cells caused an increase in
adhesion to both collagen type I and fibronectin whereas only
MDAMB231 cells additionally demonstrated an increase in
adhesion to laminin.
The PTHrP-induced changes in adhesion appear to be mediated
via integrin subunit expression as manipulation of PTHrP
expression caused parallel changes in integrin expression. When
integrin subunit expression was examined following silencing of
PTHrP, there was a reduction in integrin expression whereas
overexpression of PTHrP resulted in a significant increase.
The observed increases in adhesion and integrin expression
were not observed in cells expressing NLS-mutant PTHrP,
suggesting that PTHrP’s role in adhesion is mediated via a
mechanism that requires its transport to the cell nucleus. The
selective regulation of adhesion to ECM in the colon and breast cell
lines corresponded with changes in integrin expression. In both
cell lines, changes in adhesion to fibronectin and collagen were
paralleled by changes in a5 and b1 expression, whereas expression
of the integrin subunits a6 and b4 was only affected following
PTHrP manipulation in the MDAMB231 cell line.
Following the successful design and construction of siRNA
homologous to either a5 or a6, gene suppression was induced and
there was a decrease in protein expression, which led to a decrease
in cell adhesion. a5 forms a heterodimer with b1 to act as a receptor
for fibronectin whereas a6 forms a heterodimer with either b1 or b4
and interacts with laminin (Hynes, 2002). When cell adhesion to
the ECM proteins collagen type I, fibronectin and laminin was
examined following gene silencing of either a5 or a6, there was a
significant decrease in adhesion to only fibronectin or laminin,
respectively. The downstream effects of integrin silencing were
therefore specific and consistent with expectations. When the
effect of PTHrP overexpression was subsequently examined, both
the MDAMB231 and HT29 cells overexpressing full-length PTHrP
demonstrated a smaller decrease in a5 silencing compared with
both the vector control cell lines and the cell lines lacking the
NLS. When a6 silencing was similarly examined, although the
MDAMB231 cell lines also demonstrated a smaller decrease in
silencing compared with the vector control cell lines, there was no
discernable difference between the HT29 clones upon a6 silencing.
As subsequent examination of protein expression and cell
adhesion demonstrated a similar effect, it can be seen that PTHrP
counteracts the effects of the integrin siRNA.
Consequently, these results provide further evidence of PTHrP’s
indirect role in cell adhesion. They also correlate with the previous
findings that PTHrP’s regulation of integrin expression is
dependent on nuclear localisation and the observations regarding
the absence of a relationship between a6 and PTHrP expression in
the HT29 cell line and thereby support the hypothesis that there is
tissue-specific regulation of integrin expression by PTHrP.
When Ye et al examined the effect of PTHrP overexpression on
cell adhesion in HT29 cells, in contrast to the results described
here, they showed no change in adhesion to fibronectin. Using
different cell lines from those used here, Shen and Falzon showed
an increase in adhesion to collagen type I, fibronectin and laminin
in a colon cell line and altered adhesion to laminin only in a breast
cell line following overexpression of PTHrP. Different experi-
mental protocols were used by each group. Ye et al used crystal
violet to quantify adhesion, Shen and Falzon used alkaline
phosphatase activity, whereas MTT uptake was used in the current
study. However, it is more likely that the disparities can be
attributed to phenotypic differences in integrin subunit expression
between cell lines and even between clones of a cell line. For
example, Kiefer and Farach-Carson (2001) examined integrin cell
surface expression and detected a1b1, a2b1 and a3b1 in PC-3 cells
(Kiefer and Farach-Carson, 2001); this differed from results
described in a similar study which found only low expression of
a1b1 and a3b1 in a PC-3 clone (Kostenuik et al, 1997). To date, 18 a
and eight b subunits have been discovered and these have been
shown to form 24 different ab heterodimers. Each different a and
b subunit combination creates a different integrin–ligand inter-
action and furthermore each receptor can bind to one or more
ligand, so even a small difference in integrin subunit phenotype
may significantly alter a cell’s adhesion profile. Shen and Falzon’s
examination of integrin subunit expression revealed an increase
in expression of only a6 and b4 in MCF-7 cells, which corresponds
with their observed increase in cell adhesion to laminin only.
Similarly, PTHrP overexpressing LoVo cells demonstrated an
increase in expression of a2, a5, a6, b1 and b4, and as each of these
subunits can form receptors for collagen type I, fibronectin or
laminin this again corresponds with the increases in cell adhesion
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Figure 8 a5 promoter activity in stably transfected MDAMB231 and
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sobserved. However, although the differences in adhesion profile
can be attributed to differences in integrin expression it can be
seen that PTHrP does not universally increase integrin subunit
expression and the mechanism whereby PTHrP is able to regulate
selectively integrin expression is as yet unknown.
Primary tumours appear to exhibit a partiality for one particular
organ during metastasis, for example, breast cancer cells
predominantly metastasise to bone (Powell et al, 1991) whereas
GI tumours tend to establish secondary tumours in the liver
(Fidler, 1990; Belluco et al, 2005). Parathyroid hormone-related
protein expression in MDAMB231 cells demonstrated a correlation
with adhesion to collagen type I, fibronectin and laminin. Bone is
comprised of 95% collagen type I, with fibronectin and laminin
present within the bone marrow ECM (Vituri et al, 2000) and
laminin also a key component of the sinusoidal basement
membrane (Gu et al, 2003), so the upregulation of integrins that
bind to these ECM components may explain the fact that breast
cancer cells predominately metastasise to bone (Powell et al, 1991).
Hepatic sinusoidal endothelial cells do not possess a basement
membrane but both fibronectin and collagen type I are prevalent
in the space of Disse, which separates hepatocytes from sinusoids
(Martinez-Hernandez and Amenta, 1995), so cells which have an
increased ability to adhere to fibronectin and collagen type I (like
the PTHrP expression profile of the HT29 cell line described in this
report) but not laminin, may exhibit preferential metastasis to the
liver rather than bone.
Previous studies have shown that intranuclear PTHrP affects
proliferation (Tovar Sepulveda and Falzon, 2002), apoptosis (Aarts
et al, 2001) and adhesion (Ye et al, 2001; Shen and Falzon, 2003a,b,
2005; Shen et al, 2004). Although it has been demonstrated that
PTHrP’s effects on adhesion are dependent on its nuclear localisation,
no mechanism has been identified to date. It has been suggested that
PTHrP is a transcription factor due to the homology of PTHrP’s NLS
to the NLS of several established transcription factors, including c-
jun,c -fos and p53 (Fiaschi-Taesch and Stewart, 2003); however, no
evidence has been provided to support this hypothesis.
When the role of PTHrP in integrin transcription was examined
using the integrin subunit a5, a significant increase in promoter
activity was demonstrated in the cell lines overexpressing wild-
type PTHrP but not in cells overexpressing NLS-mutant PTHrP.
Although this result could be due to increased transfection
efficiency in cells with increased integrin expression, this is
unlikely as the transfection reagent used is a cationic lipid which is
thought to facilitate uptake of DNA through promoting interaction
of the positively charged lipid–DNA complex with the negatively
charged cell membrane and uptake through endocytosis.
Not only is the present study the first to show that PTHrP plays
a role in integrin transcription, but it also demonstrates that the
NLS is required. This dependence on the NLS is also consistent
with other results described here where the increase in adhesion
and integrin expression were reversed in cells overexpressing NLS-
mutated PTHrP.
During preparation of this manuscript, another study by Shen
and Falzon was published examining the effect of PTHrP
upregulation on a6b4 expression and Akt activation in breast
cancer cells. Subsequent to demonstrating modulation of a6b4
expression at the mRNA level (consistent with the results shown
here), they suggested that this indicated a ‘transcriptional and/or
post-transcriptional mechanism of action for PTHrP’ and also
proposed that the integrin promoter regions were necessary for
PTHrP to regulate a6b4. The results described in the present study
provide evidence that PTHrP does indeed act upon the integrin
promoter region (in this case a5) and thereby has a transcriptional
mechanism of action.
PTHrP has previously been identified as a therapeutic target
with a number of studies attempting to block PTHrP to inhibit
breast cancer metastasis to bone. For example, a recent study used
a monoclonal antibody against PTHrP to significantly reduce
osteolytic bone metastasis in a human xenograft model (Saito et al,
2005). The results presented here suggest that inhibiting PTHrP
could help to reduce metastasis to other organs, not just bone.
Furthermore, the recent success of the RNAi-based drug Cand5 in
the treatment of age-related macular degeneration (Tolentino et al,
2004) highlights the vast potential for RNAi-based drugs in the
treatment of a variety of diseases and the current study suggests
that a PTHrP-specific siRNA could be similarly effective.
It is unlikely that the effects of PTHrP on integrin transcription
is limited to one subunit and additional studies will be required to
assess whether the effects of PTHrP on integrin transcription is
limited to one subunit (a5) or whether it extends to all or a select
integrin subunits. It will also be of interest to determine the precise
mechanism whereby PTHrP modulates integrin expression. For
instance, it is unknown whether there is a direct interaction
between PTHrP and the integrin promoter sequence or whether
there is upregulation of other transcription factors, which in turn
act on the integrin promoter, that is does PTHrP upregulate
integrin transcription in a direct or indirect manner?
In summary, this study has confirmed that PTHrP regulates cell
adhesion to the ECM through modulation of integrin expression
and has demonstrated for the first time that this occurs through
regulation of transcriptional activity. The results described provide
evidence that PTHrP is involved in integrin subunit transcription
and are suggestive (albeit not conclusive) that PTHrP is a
transcription factor. The precise mechanism by which PTHrP
regulates integrin transcription would provide an interesting area
for future research.
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